Peter Schatterman

Onze Lieve Vrouwziekenhuis Hospital

Papers

1

Total Citations

99

H-Index

1

About

Dr. Peter Schatterman is a leading urologic surgeon and researcher specializing in the surgical management of benign prostatic hyperplasia (BPH), particularly in patients with large-volume prostates. His major contributions center on comparative effectiveness research, directly evaluating modern, minimally invasive techniques to optimize patient outcomes. In his landmark 2016 study from a high-volume center, Dr. Schatterman compared robotic-assisted simple prostatectomy (RASP) with holmium laser enucleation of the prostate (HoLEP) for patients with prostates exceeding 100 ml. This highly cited work (99 citations) provided critical evidence on the safety and efficacy of these approaches, helping to guide surgical decision-making for complex BPH cases. Through rigorous analysis of perioperative outcomes, he has advanced the field by clarifying the relative benefits of robotic and laser technologies. Dr. Schatterman’s research is instrumental for urologists and trainees seeking evidence-based strategies to manage challenging BPH presentations, and his work continues to shape clinical practice at the intersection of surgical innovation and patient-centered care.

Research Focus

Key Achievements

1
H-Index
1
Papers
99
Total Citations
99
Avg Citations/Paper
🏆 Most Cited Paper
Robotic Assisted Simple Prostatectomy versus Holmium Laser Enucleation of the Prostate for Lower Urinary Tract Symptoms in Patients with Large Volume Prostate: A Comparative Analysis from a High Volume Center
99 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Onze Lieve Vrouwziekenhuis Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago